BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28653215)

  • 21. Association of MiRNA-146a, MiRNA-499, IRAK1 and PADI4 Polymorphisms with Rheumatoid Arthritis in Egyptian Population.
    Shaker OG; El Boghdady NA; El Sayed AE
    Cell Physiol Biochem; 2018; 46(6):2239-2249. PubMed ID: 29734142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PADI4 Polymorphisms in Iranian Patients with Rheumatoid Arthritis.
    Shamsian E; Azarian M; Akhlaghi M; Samaei M; Jamshidi AR; Assar S; Shakiba Y; Gharibdoost F; Nourijelyani K; Mahmoudi M
    Acta Reumatol Port; 2016; 41(4):338-343. PubMed ID: 27182695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
    Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
    Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.
    Snir O; Gomez-Cabrero D; Montes A; Perez-Pampin E; Gómez-Reino JJ; Seddighzadeh M; Klich KU; Israelsson L; Ding B; Catrina AI; Holmdahl R; Alfredsson L; Klareskog L; Tegnér J; Gonzalez A; Malmström V; Padyukov L
    Arthritis Res Ther; 2014 Aug; 16(4):414. PubMed ID: 25138370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking.
    Costenbader KH; Chang SC; De Vivo I; Plenge R; Karlson EW
    Arthritis Res Ther; 2008; 10(3):R52. PubMed ID: 18462498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.
    Chen R; Wei Y; Cai Q; Duan S; Ren D; Shen J; He D; Fang M; Lv K; Cheng N; Sun S
    Rheumatol Int; 2011 Dec; 31(12):1631-4. PubMed ID: 20563870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.
    Plenge RM; Padyukov L; Remmers EF; Purcell S; Lee AT; Karlson EW; Wolfe F; Kastner DL; Alfredsson L; Altshuler D; Gregersen PK; Klareskog L; Rioux JD
    Am J Hum Genet; 2005 Dec; 77(6):1044-60. PubMed ID: 16380915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
    Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
    Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between PTPN22-1123G/C and susceptibility to rheumatoid arthritis: A systematic review and meta-analysis.
    Wu X; Yang HJ; Jung Kim M; Zhang T; Qiu JY; Park S
    Int J Rheum Dis; 2019 May; 22(5):769-780. PubMed ID: 30957405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.
    Rincón JF; Cano DL; Morales SJ; Jiménez ML; Cobos RE; Bello JR
    Clin Rheumatol; 2016 Jun; 35(6):1457-62. PubMed ID: 26951256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
    Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS
    Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of the association between PADI4 -92C/G polymorphism and rheumatoid arthritis in the Chinese population.
    Guo ZY; Zhang JX; Wu M; Mei YF; Lin XJ; Bu C; Xie Y; Wang J
    Braz J Med Biol Res; 2017 Aug; 50(10):e6115. PubMed ID: 28832760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. rs2476601 in PTPN22 gene in rheumatoid arthritis and periodontitis-a possible interface?
    Schulz S; Zimmer P; Pütz N; Jurianz E; Schaller HG; Reichert S
    J Transl Med; 2020 Oct; 18(1):389. PubMed ID: 33059697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism of protein tyrosine phosphatase non-receptor type 22 and protein arginine deiminase 4 gene among Ghanaian rheumatoid arthritis patients: A case-control study.
    Sakyi SA; Boateng AO; Fondjo LA; Mensah KY; Opoku S; Senu E; Buckman TA; Sampson JE
    Int J Rheum Dis; 2022 Jul; 25(7):781-786. PubMed ID: 35607828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
    Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
    Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies,
    Guderud K; Mæhlen MT; Nordang GBN; Viken MK; Andreassen BK; Molberg Ø; Flåm ST; Lie BA
    J Rheumatol; 2018 Aug; 45(9):1211-1219. PubMed ID: 29858238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.